Coherent Market Insights

Targeted Drug Delivery Market to Surpass US$ 22,704 Million by 2030

Targeted Drug Delivery Market to Surpass US$ 22,704 Million by 2030 - Coherent Market Insights

Publish In: Apr 15, 2022

Global Targeted Drug Delivery Market, by Disease Type (Cardiovascular Diseases, Pulmonary Diseases, Infectious Diseases, Endocrine Diseases, and Oncological Disorders), by Application (First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), and Third Order Targeting (Intracellular Targeting), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 6,960 million in 2022 and is expected to exhibit a CAGR of 15.9 % over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on the research and development of novel targeted drug delivery systems. This is expected to drive the market growth over the forecast period.

For instance, in November 2021, Ikena Oncology, a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients, announced the U.S. Food and Drug Administration (FDA) acceptance of Investigational New Drug (IND) application of novel TEAD inhibitor IK – 930. Ikena is developing IK – 930 as a targeted therapy for patients with cancers that exhibit genetic alterations across the hippo pathway. IK – 930 is designed to selectively bind TEAD and disrupt TEAD – dependent transcription of key genes involved in cancer progression, metastases, and therapeutic resistance.

Moreover, in May 2021, MDimmune, Inc. a leading cell-derived vesicles (CDVs) company in South Korea, successfully demonstrated BioDrone in collaboration with Seoul National University. BioDrone platform is CDV based drug delivery system (DDS), which selectively delivers various drugs to specific lesions by loading them on the CDV.

Global Targeted Drug Delivery Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 a pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 489 million cases of coronavirus disease (COVID-19) were reported till April 3, 2022, across the globe.

The COVID -19 is an incomparable global public health emergency that has affected almost every industry and the long-term effects are projected to impact the future industry growth.

The pandemic reduced most academic, industrial, and governmental research related to clinical studies and it was redirected COVID-19 research.

Browse 38 Market Data Tables and 26 Figures spread through 154 Pages and in-depth TOC on “Targeted Drug Delivery Market” - Global Forecast to 2030, by Disease Type (Cardiovascular Diseases, Pulmonary Diseases, Infectious Diseases, Endocrine Diseases, and Oncological Disorders), by Application (First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), and Third Order Targeting (Intracellular Targeting), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the global targeted drug delivery market, click the link below:

https://www.coherentmarketinsights.com/market-insight/targeted-drug-delivery-market-5003

Key players operating in the market are focusing on the adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market. For instance, in September 2021, Cyclica, the partner of choice for data driven drug discovery, and IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapies, had entered in a collaboration agreement on IMPACT Therapeutics’ differentiated targeted anti-cancer drug development.

Key Takeaways of the Global Targeted Drug Delivery Market:

  • The global targeted drug delivery market is expected to exhibit a CAGR of 15.9% over the forecast period, owing to rising the research and development of targeted drug delivery. For instance, in October 2021, AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing, and active material science solution, announced its patented Cartridge Pump System (CPS), designed for the multidose delivery of preserved and non-preserved drug formulations.
  • Among disease type, the oncological disorders segment is expected to account for the largest market share during the forecast period, owing to increasing cancer prevalence and rising research and development. For instance, the American Cancer Society estimated that prostate cancer new cases in the U.S for 2022 will be about 2,64,490.
  • Key players operating in the global targeted drug delivery market include AbbVie Inc., Ablynx NV by Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca PLC, Boston Scientific Corporation, Becton, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan Liposome Company, Ltd., and 3M.

 

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail


Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Created billion dollars of revenue impact on thousands of clients

trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.